BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32437911)

  • 1. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
    Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.
    Fu JF; Liang DC; Shih LY
    Am J Clin Pathol; 2007 Jan; 127(1):24-30. PubMed ID: 17145626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.
    Albouhair S; Morgado E; Lavau C
    PLoS One; 2013; 8(8):e72261. PubMed ID: 23977266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of mixed-lineage leukemia.
    Muntean AG; Hess JL
    Annu Rev Pathol; 2012; 7():283-301. PubMed ID: 22017583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
    Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
    Cano F; Drynan LF; Pannell R; Rabbitts TH
    Oncogene; 2008 Mar; 27(13):1945-50. PubMed ID: 17906700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis.
    Dobson CL; Warren AJ; Pannell R; Forster A; Lavenir I; Corral J; Smith AJ; Rabbitts TH
    EMBO J; 1999 Jul; 18(13):3564-74. PubMed ID: 10393173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.
    Fazzina R; Lombardini L; Mezzanotte L; Roda A; Hrelia P; Pession A; Tonelli R
    Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
    Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
    Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Young K; Loberg MA; Eudy E; Schwartz LS; Mujica KD; Trowbridge JJ
    Exp Hematol; 2020 Sep; 89():61-67.e3. PubMed ID: 32768438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.
    Horton SJ; Walf-Vorderwülbecke V; Chatters SJ; Sebire NJ; de Boer J; Williams O
    Blood; 2009 May; 113(20):4922-9. PubMed ID: 19029444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
    Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos.
    Belt AJ; Grant S; Tombes RM; Rothschild SC
    PLoS Genet; 2024 Jun; 20(6):e1011308. PubMed ID: 38829886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach.
    Binato R; Meyer C; Macedo-Silva ML; Garcia D; Figueiredo A; Hofmann J; Vieira TP; Abdelhay E; Marschalek R
    Cancer Lett; 2013 Sep; 338(2):249-54. PubMed ID: 23562474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11q23 rearrangements in acute leukemia.
    Rubnitz JE; Behm FG; Downing JR
    Leukemia; 1996 Jan; 10(1):74-82. PubMed ID: 8558942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MLL recombinome of acute leukemias in 2013.
    Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.